Vicente-Zurdo, D.; Brunetti, L.; Piemontese, L.; Guedes, B.; Cardoso, S.M.; Chavarria, D.; Borges, F.; Madrid, Y.; Chaves, S.; Santos, M.A.
Rivastigmine–Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases. Int. J. Mol. Sci. 2023, 24, 8312.
https://doi.org/10.3390/ijms24098312
AMA Style
Vicente-Zurdo D, Brunetti L, Piemontese L, Guedes B, Cardoso SM, Chavarria D, Borges F, Madrid Y, Chaves S, Santos MA.
Rivastigmine–Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases. International Journal of Molecular Sciences. 2023; 24(9):8312.
https://doi.org/10.3390/ijms24098312
Chicago/Turabian Style
Vicente-Zurdo, David, Leonardo Brunetti, Luca Piemontese, Beatriz Guedes, Sandra M. Cardoso, Daniel Chavarria, Fernanda Borges, Yolanda Madrid, SÃlvia Chaves, and M. Amélia Santos.
2023. "Rivastigmine–Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases" International Journal of Molecular Sciences 24, no. 9: 8312.
https://doi.org/10.3390/ijms24098312
APA Style
Vicente-Zurdo, D., Brunetti, L., Piemontese, L., Guedes, B., Cardoso, S. M., Chavarria, D., Borges, F., Madrid, Y., Chaves, S., & Santos, M. A.
(2023). Rivastigmine–Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases. International Journal of Molecular Sciences, 24(9), 8312.
https://doi.org/10.3390/ijms24098312
